Skip to main content
61°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biotricity Inc
(NQ:
BTCY
)
1.190
-0.020 (-1.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biotricity Inc
< Previous
1
2
3
4
Next >
Biotricity to Join Russell Microcap(R) Index
June 23, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the...
From
Biotricity, Inc.
Via
AccessWire
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
May 23, 2022
REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Issues Shareholder Update
May 05, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Biotricity, Inc.
Via
AccessWire
Exposures
COVID-19
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
March 22, 2022
- Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc....
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Inc. (NASDAQ: BTCY) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 11, 2022
Via
Investor Brand Network
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
March 08, 2022
Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...
From
Biotricity, Inc.
Via
AccessWire
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th
March 04, 2022
- Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared,...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
February 23, 2022
- Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
February 14, 2022
Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End...
From
Biotricity, Inc.
Via
AccessWire
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022
February 08, 2022
Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE /...
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device
January 24, 2022
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022...
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Expands Distribution of New Bioheart Device on Amazon.com
December 28, 2021
New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your Smartphone Now Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle Solution REDWOOD...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Completes $12 Million Non-Dilutive Debt Financing
December 27, 2021
Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms 5-year term deal strengthens balance sheet, positions company for...
From
Biotricity, Inc.
Via
AccessWire
Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter
December 07, 2021
The Company believes that it is "well-positioned for 2022." Letter highlights milestones, products roadmap, growth strategy and 2022 goals REDWOOD CITY, CA / ACCESSWIRE / December 7, 2021 / Biotricity,...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor
November 10, 2021
From
Biotricity, Inc.
Via
Business Wire
Biotricity Releases Fiscal 2022 Second Quarter Financial Results
November 04, 2021
- Company reports tenth consecutive quarter of triple-digit year-over-year revenue growth - Strongest balance sheet since inception REDWOOD CITY, CA / ACCESSWIRE / November 4, 2021 / Biotricity Inc....
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Biotricity to Report Second Quarter Fiscal 2022 Financial Results on November 4, 2021
November 02, 2021
Management to Host Conference Call and Live Webcast at 5pm ET REDWOOD CITY, CA / ACCESSWIRE / November 2, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Discuss its Breakthrough Patient Monitoring Solutions at Virtual LD Micro Main Event XIV on Oct. 13th
October 12, 2021
REDWOOD CITY, CA / ACCESSWIRE / October 12, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
October 07, 2021
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardiac...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th
October 06, 2021
Founder and CEO Waqaas Al Siddiq and Members of Biotricity Management Team to Attend Opening Bell Ceremony on Thursday, October 7, 2021 at 9:30am E.T. REDWOOD CITY, CA / ACCESSWIRE / October 6, 2021 /...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30
September 28, 2021
REDWOOD CITY, CA / ACCESSWIRE / September 28, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Chief Executive Officer...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd
September 21, 2021
Biokit is the Expansion of the Company's Bioflux Cardiac-Diagnostic Offering Kits on Track for Launch in Early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 21, 2021 / Biotricity Inc. (NASDAQ:BTCY), a...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management
September 14, 2021
Company Expects New Personal Medical Device Kit to be available to customer by early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 14, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock
September 13, 2021
Underwritten Public Offering of Common Stock Resulted in Total Gross Proceeds of $16 Million REDWOOD CITY, CA / ACCESSWIRE / September 13, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference
September 08, 2021
Company's Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity Raise REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Completes Nasdaq Listing
August 30, 2021
Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
August 26, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of an underwritten public...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing
August 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 25, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends to offer shares of its...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter
August 16, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial results for its fiscal...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021
August 12, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 12, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.